Joop de Langen, Longarts, NKI-AVL

Biografie
Joop de Langen is a thoracic oncologist at the Antoni van Leeuwenhoek hospital in Amsterdam, The Netherlands. He specialized in the targeted treatment of driver positive NSCLC.

Samenvatting
Multiple new drugs have been introduced in the recent years for EGFR mutation positive NSCLC, both in first as well as later lines. Choosing the first line regimen has consequences for later line options. In this presentation we will discuss how to navigate through the field of these innovations.